Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Asthma

Free Subscription Articles published in Pulm Pharmacol Ther Retrieve available abstracts of 11 articles: HTML format

Single Articles

September 2025
1. XIAO B, Zhou G, Hou L, Yang L, et al
   Icaritin protects against airway inflammation by inhibiting the TLR4/NF-kappaB pathway in vivo and in vitro.
   Pulm Pharmacol Ther. 2025;90:102380.
   PubMed     Abstract available
   
   
   August 2025
2. PARK HJ, Lee CH, Lee JK, Kim DK, et al
   Clinical remission at two years post-diagnosis of asthma and its association with clinical outcomes: A retrospective cohort study in asthma patients with maintenance inhaler therapy.
   Pulm Pharmacol Ther. 2025 Aug 5:102381. doi: 10.1016/j.pupt.2025.102381.
   PubMed     Abstract available
   
   
   July 2025
3. MATERA MG, Calzetta L, De Biase A, Lauro D, et al
   A disproportionality analysis of diabetes mellitus in patients treated with biologics for asthma and related conditions using FAERS data.
   Pulm Pharmacol Ther. 2025;90:102377.
   PubMed     Abstract available
   
   
   June 2025
4. OKWUOFU EO, Yong ACH, Lim JCW, Stanslas J, et al
   The era of multiple biologics: Is combination and switching an option in the management of severe asthma?
   Pulm Pharmacol Ther. 2025;90:102375.
   PubMed     Abstract available
   
   
   
5. SALVADORI M, Singh D, Mathews K, Girardello L, et al
   The low global warming potential propellant HFA-152a does not induce bronchoconstriction or impair mucociliary clearance.
   Pulm Pharmacol Ther. 2025;89:102358.
   PubMed     Abstract available
   
   
   February 2025
6. GALA CK, Sandeep, Pande AH, Sharma SS, et al
   Bispecific Domain Antibody Attenuates Airway Hyperresponsiveness and Pulmonary Inflammation in Ovalbumin-Lipopolysaccharide Induced Asthma Model by Inhibiting IL-23 and TNF-alpha.
   Pulm Pharmacol Ther. 2025 Feb 24:102347. doi: 10.1016/j.pupt.2025.102347.
   PubMed     Abstract available
   
   
   December 2024
7. PISTOCCHINI E, Carrillo Heredero AM, Mazan M, Couetil L, et al
   Corrigendum to "Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat" [Pulm. Pharmacol. Therapeut. (88), March 2025, 102342].
   Pulm Pharmacol Ther. 2024 Dec 19:102343. doi: 10.1016/j.pupt.2024.102343.
   PubMed    
   
   
   
8. PISTOCCHINI E, Carrillo Heredero AM, Mazan M, Couetil L, et al
   Clinical efficacy of inhaled corticosteroids in equine asthma: A meta-analysis and number needed to treat.
   Pulm Pharmacol Ther. 2024;88:102342.
   PubMed     Abstract available
   
   
   
9. MATERA MG, Calzetta L, Rinaldi B, Belardo C, et al
   Interaction between fluticasone furoate and umeclidinium in passively sensitized isolated human airways.
   Pulm Pharmacol Ther. 2024;87:102331.
   PubMed     Abstract available
   
   
   November 2024
10. D B, I A, I B, A B, et al
    Triple inhaled therapy in asthma: beliefs, behaviours and doubts.
    Pulm Pharmacol Ther. 2024 Nov 19:102333. doi: 10.1016/j.pupt.2024.102333.
    PubMed     Abstract available
    
    
    October 2024
11. SHI H, Chen Z, Lei Q, Ma D, et al
    Chest CT assess the impact of omalizumab treatment on airway remodeling in refractory asthma.
    Pulm Pharmacol Ther. 2024;87:102329.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Asthma is free of charge.